Raras
Buscar doenças, sintomas, genes...
Ataxia cerebelosa autossômica recessiva
ORPHA:1172DOENÇA RARA

As Ataxias Cerebelares Autossômicas Recessivas (ARCA) são um grupo diverso de doenças neurológicas raras que envolvem tanto o sistema nervoso central quanto o periférico (e, em alguns casos, outros sistemas e órgãos do corpo), e se caracterizam pela deterioração ou desenvolvimento anormal do cerebelo e da medula espinhal, com início, na maioria dos casos, antes dos 20 anos de idade.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

As Ataxias Cerebelares Autossômicas Recessivas (ARCA) são um grupo diverso de doenças neurológicas raras que envolvem tanto o sistema nervoso central quanto o periférico (e, em alguns casos, outros sistemas e órgãos do corpo), e se caracterizam pela deterioração ou desenvolvimento anormal do cerebelo e da medula espinhal, com início, na maioria dos casos, antes dos 20 anos de idade.

Pesquisas ativas
2 ensaios
3 total registrados no ClinicalTrials.gov
Publicações científicas
179 artigos
Último publicado: 2026
Medicamentos
11 registrados
CHENODIOL, OMAVELOXOLONE, VATIQUINONE

Tem tratamento?

11 medicamentos registrados
Ver detalhes, fases e interações →
CHENODIOLOMAVELOXOLONEVATIQUINONEPIOGLITAZONEINTERFERON GAMMA-1BLOVASTATINVARENICLINELERIGLITAZONEEPOETIN ALFAROSUVASTATIN

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
3.3
Portugal
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
130 sintomas
🦴
Ossos e articulações
67 sintomas
👁️
Olhos
62 sintomas
💪
Músculos
40 sintomas
😀
Face
40 sintomas
🫃
Digestivo
33 sintomas

+ 375 sintomas em outras categorias

Características mais comuns

Sacadas dismétricas
Comprometimento cognitivo
Nível urinário elevado de álcool biliar
Defeitos da cadeia respiratória mitocondrial
Anormalidade dos nervos periféricos
Concentração elevada de álcool biliar circulante
876sintomas
Sem dados (876)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 876 características clínicas mais associadas, ordenadas por frequência.

Sacadas dismétricasDysmetric saccades
Comprometimento cognitivoCognitive impairment
Nível urinário elevado de álcool biliarElevated urinary bile alcohol level
Defeitos da cadeia respiratória mitocondrialMitochondrial respiratory chain defects
Anormalidade dos nervos periféricosAbnormality of peripheral nerves

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico179PubMed
Últimos 10 anos121publicações
Pico202214 papers
Linha do tempo
2026Hoje · 2026🧪 2003Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

65 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

POLGDNA polymerase subunit gamma-1Candidate gene tested inTolerante
FUNÇÃO

Catalytic subunit of DNA polymerase gamma solely responsible for replication of mitochondrial DNA (mtDNA). Replicates both heavy and light strands of the circular mtDNA genome using a single-stranded DNA template, RNA primers and the four deoxyribonucleoside triphosphates as substrates (PubMed:11477093, PubMed:11897778, PubMed:15917273, PubMed:19837034, PubMed:9558343). Has 5' -> 3' polymerase activity. Functionally interacts with TWNK and SSBP1 at the replication fork to form a highly processiv

LOCALIZAÇÃO

MitochondrionMitochondrion matrix, mitochondrion nucleoid

VIAS BIOLÓGICAS (1)
Strand-asynchronous mitochondrial DNA replication
MECANISMO DE DOENÇA

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1

A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
48.3 TPM
Linfócitos
42.0 TPM
Baço
41.5 TPM
Útero
40.9 TPM
Pulmão
38.7 TPM
OUTRAS DOENÇAS (11)
sensory ataxic neuropathy, dysarthria, and ophthalmoparesismitochondrial DNA depletion syndrome 4bmitochondrial DNA depletion syndrome 4amitochondrial disease
HGNC:9179UniProt:P54098
VLDLRVery low-density lipoprotein receptorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Multifunctional cell surface receptor that binds VLDL and transports it into cells by endocytosis and therefore plays an important role in energy metabolism. Also binds to a wide range of other molecules including Reelin/RELN or apolipoprotein E/APOE-containing ligands as well as clusterin/CLU (PubMed:24381170, PubMed:30873003). In the off-state of the pathway, forms homooligomers or heterooligomers with LRP8 (PubMed:30873003). Upon binding to ligands, homooligomers are rearranged to higher orde

LOCALIZAÇÃO

Cell membraneMembrane, clathrin-coated pit

VIAS BIOLÓGICAS (3)
VLDL clearanceVLDLR internalisation and degradationReelin signalling pathway
MECANISMO DE DOENÇA

Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 1

An autosomal recessive, congenital, non-progressive cerebellar ataxia associated with disturbed equilibrium, delayed ambulation, intellectual disability, cerebellar hypoplasia and mild cerebral gyral simplification. Additional features include short stature, strabismus, pes planus and, rarely, seizures.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
81.6 TPM
Artéria tibial
18.7 TPM
Coração - Átrio
18.7 TPM
Coração - Ventrículo esquerdo
16.5 TPM
Fallopian Tube
15.2 TPM
OUTRAS DOENÇAS (2)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1cerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:12698UniProt:P98155
CTDP1RNA polymerase II subunit A C-terminal domain phosphataseCandidate gene tested inTolerante
FUNÇÃO

Processively dephosphorylates 'Ser-2' and 'Ser-5' of the heptad repeats YSPTSPS in the C-terminal domain of the largest RNA polymerase II subunit. This promotes the activity of RNA polymerase II. Plays a role in the exit from mitosis by dephosphorylating crucial mitotic substrates (USP44, CDC20 and WEE1) that are required for M-phase-promoting factor (MPF)/CDK1 inactivation

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindle poleMidbody

VIAS BIOLÓGICAS (10)
TP53 Regulates Transcription of DNA Repair GenesFormation of HIV elongation complex in the absence of HIV TatFormation of the HIV-1 Early Elongation ComplexAbortive elongation of HIV-1 transcript in the absence of TatFormation of HIV-1 elongation complex containing HIV-1 Tat
MECANISMO DE DOENÇA

Congenital cataracts, facial dysmorphism, and neuropathy

An autosomal recessive developmental disorder characterized by a complex clinical phenotype with seemingly unrelated features involving multiple organs and systems. Developmental abnormalities include congenital cataracts and microcorneae, hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, facial dysmorphism and hypogonadism. Central nervous system involvement, with cerebral and spinal cord atrophy, may be the result of disrupted development with superimposed degenerative changes. Affected individuals are prone to severe rhabdomyolysis after viral infections and to serious complications related to general anesthesia (such as pulmonary edema and epileptic seizures).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
34.3 TPM
Skin Sun Exposed Lower leg
22.0 TPM
Skin Not Sun Exposed Suprapubic
18.4 TPM
Sangue
17.1 TPM
Baço
16.3 TPM
OUTRAS DOENÇAS (1)
congenital cataracts-facial dysmorphism-neuropathy syndrome
HGNC:2498UniProt:Q9Y5B0
SIL1Nucleotide exchange factor SIL1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for protein translocation and folding in the endoplasmic reticulum (ER). Functions as a nucleotide exchange factor for the ER lumenal chaperone HSPA5

LOCALIZAÇÃO

Endoplasmic reticulum lumen

MECANISMO DE DOENÇA

Marinesco-Sjoegren syndrome

Autosomal recessive multisystem disorder which is characterized by cerebellar ataxia due to cerebellar atrophy, with Purkinje and granule cell loss and myopathy featuring marked muscle replacement with fat and connective tissue. Other cardinal features include bilateral cataracts, hypergonadotrophic hypogonadism and mild to severe intellectual disability. Skeletal abnormalities, short stature, dysarthria, strabismus and nystagmus are also frequent findings. Mutational inactivation of this protein may result in ER stress-induced cell death signaling or malfunctioning chaperone machineries that mishandle client proteins which are critical for the organs targeted in MSS.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
59.1 TPM
Fibroblastos
41.1 TPM
Glândula adrenal
36.4 TPM
Tireoide
32.5 TPM
Pituitária
31.3 TPM
OUTRAS DOENÇAS (1)
Marinesco-Sjogren syndrome
HGNC:24624UniProt:Q9H173
SYT14Synaptotagmin-14Candidate gene tested inRestrito
FUNÇÃO

May be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues. Is Ca(2+)-independent

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 11

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR11 is associated with psychomotor retardation.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
8.0 TPM
Cerebelo
7.7 TPM
Pituitária
5.4 TPM
Tireoide
2.8 TPM
Testículo
2.6 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 11
HGNC:23143UniProt:Q8NB59
TUBB2BTubulin beta-2B chainCandidate gene tested inAltamente restrito
FUNÇÃO

Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers (PubMed:23001566, PubMed:26732629, PubMed:28013290). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. Plays a critical role in proper axon guidance in both central and periph

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (10)
HCMV Early EventsPKR-mediated signalingGap junction assemblyAggrephagyAssembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Cortical dysplasia, complex, with other brain malformations 7

A malformation of the cortex in which the brain surface is irregular and characterized by an excessive number of small gyri with abnormal lamination. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
377.8 TPM
Brain Nucleus accumbens basal ganglia
248.1 TPM
Substância negra
229.1 TPM
Hipotálamo
205.3 TPM
Brain Caudate basal ganglia
203.2 TPM
OUTRAS DOENÇAS (4)
complex cortical dysplasia with other brain malformations 7tubulinopathy-associated dysgyriacerebellar ataxia, intellectual disability, and dysequilibriumcongenital fibrosis of extraocular muscles
HGNC:30829UniProt:Q9BVA1
ZNF423Zinc finger protein 423Candidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor that can both act as an activator or a repressor depending on the context. Plays a central role in BMP signaling and olfactory neurogenesis. Associates with SMADs in response to BMP2 leading to activate transcription of BMP target genes. Acts as a transcriptional repressor via its interaction with EBF1, a transcription factor involved in terminal olfactory receptor neurons differentiation; this interaction preventing EBF1 to bind DNA and activate olfactory-specific genes. In

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2
MECANISMO DE DOENÇA

Nephronophthisis 14

An autosomal recessive disorder manifesting as infantile-onset kidney disease, cerebellar vermis hypoplasia, and situs inversus. Nephronophthisis is a progressive tubulo-interstitial kidney disorder histologically characterized by modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
8.3 TPM
Fallopian Tube
8.3 TPM
Cerebelo
8.0 TPM
Cervix Endocervix
7.9 TPM
Tecido adiposo
7.0 TPM
OUTRAS DOENÇAS (3)
nephronophthisis 14nephronophthisis 2Joubert syndrome with oculorenal defect
HGNC:16762UniProt:Q2M1K9
PITRM1Presequence protease, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Metalloendopeptidase of the mitochondrial matrix that functions in peptide cleavage and degradation rather than in protein processing (PubMed:10360838, PubMed:16849325, PubMed:19196155, PubMed:24931469). Has an ATP-independent activity (PubMed:16849325). Specifically cleaves peptides in the range of 5 to 65 residues (PubMed:19196155). Shows a preference for cleavage after small polar residues and before basic residues, but without any positional preference (PubMed:10360838, PubMed:19196155, PubM

LOCALIZAÇÃO

MitochondrionMitochondrion matrix

VIAS BIOLÓGICAS (1)
Mitochondrial protein import
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 30

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR30 is a progressive disease characterized by childhood-onset global developmental delay with variably impaired intellectual development, motor dysfunction, and cerebellar ataxia. Affected individuals may also have psychiatric abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
58.3 TPM
Aorta
58.3 TPM
Artéria tibial
56.3 TPM
Testículo
52.8 TPM
Útero
50.9 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 30
HGNC:HGNC:17663UniProt:Q5JRX3
TPP1Tripeptidyl-peptidase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Lysosomal serine protease with tripeptidyl-peptidase I activity (PubMed:11054422, PubMed:19038966, PubMed:19038967). May act as a non-specific lysosomal peptidase which generates tripeptides from the breakdown products produced by lysosomal proteinases (PubMed:11054422, PubMed:19038966, PubMed:19038967). Requires substrates with an unsubstituted N-terminus (PubMed:19038966)

LOCALIZAÇÃO

LysosomeMelanosome

VIAS BIOLÓGICAS (1)
XBP1(S) activates chaperone genes
MECANISMO DE DOENÇA

Ceroid lipofuscinosis, neuronal, 2

A form of neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment pattern seen most often in CLN2 consists of curvilinear profiles.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
192.2 TPM
Glândula adrenal
173.0 TPM
Fibroblastos
138.0 TPM
Pulmão
131.9 TPM
Útero
116.5 TPM
OUTRAS DOENÇAS (2)
autosomal recessive spinocerebellar ataxia 7neuronal ceroid lipofuscinosis 2
HGNC:2073UniProt:O14773
PRDX3Thioredoxin-dependent peroxide reductase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides (PubMed:17707404, PubMed:29438714, PubMed:33889951, PubMed:7733872). Acts synergistically with MAP3K13 to regulate the activation of NF-kappa-B in the cytosol (PubMed:12492477). Required for the maintenance of physical strength (By similarity)

LOCALIZAÇÃO

MitochondrionCytoplasmEarly endosome

VIAS BIOLÓGICAS (1)
Detoxification of Reactive Oxygen Species
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 32

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR32 is characterized by the onset of gait ataxia in the second or third decades of life. Other classic features include upper limb ataxia, oculomotor signs, dysphagia, and dysarthria. Some patients may have hyper- or hypokinetic movement abnormalities. Brain imaging shows cerebellar atrophy. Atrophy can extend to the brainstem and medullary olives.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
502.2 TPM
Linfócitos
337.5 TPM
Fibroblastos
288.3 TPM
Músculo esquelético
250.0 TPM
Fígado
216.9 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia, autosomal recessive 32corneal dystrophy, punctiform and polychromatic pre-descemet
HGNC:HGNC:9354UniProt:P30048
SCYL1N-terminal kinase-like proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Regulates COPI-mediated retrograde protein traffic at the interface between the Golgi apparatus and the endoplasmic reticulum (PubMed:18556652). Involved in the maintenance of the Golgi apparatus morphology (PubMed:26581903) Acts as a transcriptional activator. It binds to three different types of GC-rich DNA binding sites (box-A, -B and -C) in the beta-polymerase promoter region. It also binds to the TERT promoter region

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeEndoplasmic reticulum-Golgi intermediate compartmentGolgi apparatus, cis-Golgi networkCytoplasmNucleus

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 21

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR21 is characterized by cerebellar atrophy and ataxia with onset in early childhood. Patients also manifest recurrent episodes of liver failure, hepatic fibrosis and a peripheral neuropathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
109.2 TPM
Ovário
108.0 TPM
Cervix Endocervix
107.9 TPM
Cervix Ectocervix
106.3 TPM
Testículo
106.2 TPM
OUTRAS DOENÇAS (1)
acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome
HGNC:14372UniProt:Q96KG9
CEP41Centrosomal protein of 41 kDaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required during ciliogenesis for tubulin glutamylation in cilium. Probably acts by participating in the transport of TTLL6, a tubulin polyglutamylase, between the basal body and the cilium

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, ciliumCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 15

An autosomal recessive disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis and polydactyly.

OUTRAS DOENÇAS (3)
Joubert syndrome 15Joubert syndromeJoubert syndrome with ocular defect
HGNC:12370UniProt:Q9BYV8
ANO10Anoctamin-10Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Does not exhibit calcium-activated chloride channel (CaCC) activity. Can inhibit the activity of ANO1

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Induction of Cell-Cell FusionStimuli-sensing channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 10

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR10 is characterized by onset in the teenage or young adult years of gait and limb ataxia, dysarthria, and nystagmus associated with marked cerebellar atrophy on brain imaging.

OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 10
HGNC:25519UniProt:Q9NW15
PEX6Peroxisomal ATPase PEX6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the PEX1-PEX6 AAA ATPase complex, a protein dislocase complex that mediates the ATP-dependent extraction of the PEX5 receptor from peroxisomal membranes, an essential step for PEX5 recycling (PubMed:16314507, PubMed:16854980, PubMed:21362118, PubMed:29884772). Specifically recognizes PEX5 monoubiquitinated at 'Cys-11', and pulls it out of the peroxisome lumen through the PEX2-PEX10-PEX12 retrotranslocation channel (PubMed:29884772). Extraction by the PEX1-PEX6 AAA ATPase complex is

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome membraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Peroxisomal protein import
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 4

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Fallopian Tube
66.8 TPM
Ovário
64.6 TPM
Cerebelo
61.1 TPM
Cérebro - Hemisfério cerebelar
58.5 TPM
Pituitária
55.1 TPM
OUTRAS DOENÇAS (6)
peroxisome biogenesis disorder 4Bperoxisome biogenesis disorder 4A (Zellweger)peroxisome biogenesis disorder due to PEX6 defectobsolete Heimler syndrome
HGNC:8859UniProt:Q13608
FLVCR1Choline/ethanolamine transporter FLVCR1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Uniporter that mediates the transport of extracellular choline and ethanolamine into cells, thereby playing a key role in phospholipid biosynthesis (PubMed:37100056, PubMed:38693265, PubMed:38778100, PubMed:39306721). Choline and ethanolamine are the precursors of phosphatidylcholine and phosphatidylethanolamine, respectively, the two most abundant phospholipids (PubMed:38693265, PubMed:38778100). Transport is not coupled with proton transport and is exclusively driven by the choline (or ethanol

LOCALIZAÇÃO

Cell membraneMitochondrion membrane

VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Retinopathy-sensory neuropathy syndrome

An autosomal recessive neurodegenerative syndrome beginning in infancy with areflexia and retinitis pigmentosa. Nyctalopia (night blindness) and peripheral visual field loss are usually evident during late childhood or teenage years, with subsequent progressive constriction of the visual fields and loss of central retinal function over time. A sensory ataxia caused by degeneration of the posterior columns of the spinal cord results in a loss of proprioceptive sensation that is clinically evident in the second decade of life and gradually progresses. Scoliosis, camptodactyly, achalasia, gastrointestinal dysmotility, and a sensory peripheral neuropathy are variable features of the disease. Affected individuals have no clinical or radiological evidence of cerebral or cerebellar involvement. Some patients have pain insensitivity and commonly manifest self-injury, ulcers and amputations.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
16.6 TPM
Pituitária
14.5 TPM
Cérebro - Hemisfério cerebelar
12.5 TPM
Cerebelo
9.8 TPM
Intestino delgado
8.4 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
posterior column ataxia-retinitis pigmentosa syndromeneurodevelopmental disorder with microcephaly, absent speech, and hypotonia
HGNC:24682UniProt:Q9Y5Y0
TBCETubulin-specific chaperone ECandidate gene tested inTolerante
FUNÇÃO

Tubulin-folding protein; involved in the second step of the tubulin folding pathway and in the regulation of tubulin heterodimer dissociation. Required for correct organization of microtubule cytoskeleton and mitotic splindle, and maintenance of the neuronal microtubule network

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Post-chaperonin tubulin folding pathway
MECANISMO DE DOENÇA

Hypoparathyroidism-retardation-dysmorphism syndrome

An autosomal recessive multisystem disorder characterized by hypoparathyroidism, intrauterine and postnatal growth retardation, psychomotor retardation, epilepsy, microcephaly, and facial dysmorphism.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
38.8 TPM
Cérebro - Hemisfério cerebelar
35.3 TPM
Fibroblastos
31.5 TPM
Artéria tibial
31.4 TPM
Cerebelo
31.3 TPM
OUTRAS DOENÇAS (4)
autosomal recessive Kenny-Caffey syndromeencephalopathy, progressive, with amyotrophy and optic atrophyhypoparathyroidism-retardation-dysmorphism syndromeearly-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome
HGNC:11582UniProt:Q15813
SLC9A1Sodium/hydrogen exchanger 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Electroneutral Na(+) /H(+) antiporter that extrudes Na(+) in exchange for external protons driven by the inward sodium ion chemical gradient, protecting cells from acidification that occurs from metabolism (PubMed:11350981, PubMed:11532004, PubMed:14680478, PubMed:15035633, PubMed:15677483, PubMed:17073455, PubMed:17493937, PubMed:22020933, PubMed:27650500, PubMed:32130622, PubMed:7110335, PubMed:7603840). Exchanges intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry (By similar

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (2)
Hyaluronan degradationSodium/Proton exchangers
MECANISMO DE DOENÇA

Lichtenstein-Knorr syndrome

An autosomal recessive neurologic disorder characterized by progressive cerebellar ataxia and severe progressive sensorineural hearing loss.

EXPRESSÃO TECIDUAL(Ubíquo)
Estômago
33.1 TPM
Glândula salivar
30.3 TPM
Cólon transverso
29.6 TPM
Pulmão
29.2 TPM
Cervix Ectocervix
28.0 TPM
OUTRAS DOENÇAS (1)
Lichtenstein-Knorr syndrome
HGNC:11071UniProt:P19634
THG1LProbable tRNA(His) guanylyltransferaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Adds a GMP to the 5'-end of tRNA(His) after transcription and RNase P cleavage. This step is essential for proper recognition of the tRNA and for the fidelity of protein synthesis (Probable). Also functions as a guanyl-nucleotide exchange factor/GEF for the MFN1 and MFN2 mitofusins thereby regulating mitochondrial fusion (PubMed:25008184, PubMed:27307223). By regulating both mitochondrial dynamics and bioenergetic function, it contributes to cell survival following oxidative stress (PubMed:25008

LOCALIZAÇÃO

CytoplasmMitochondrion outer membrane

VIAS BIOLÓGICAS (1)
tRNA modification in the nucleus and cytosol
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 28

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR28 patients manifest mild motor developmental delay, gait ataxia, and dysarthria. Some patients show mildly impaired intellectual development. Disease onset is in early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
20.2 TPM
Fibroblastos
17.3 TPM
Bladder
15.8 TPM
Útero
15.3 TPM
Cervix Ectocervix
15.1 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 28
HGNC:HGNC:26053UniProt:Q9NWX6
KIAA0586Protein TALPID3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for ciliogenesis and sonic hedgehog/SHH signaling. Required for the centrosomal recruitment of RAB8A and for the targeting of centriole satellite proteins to centrosomes such as of PCM1. May play a role in early ciliogenesis in the disappearance of centriolar satellites that preceeds ciliary vesicle formation (PubMed:24421332). Involved in regulation of cell intracellular organization. Involved in regulation of cell polarity (By similarity). Required for asymmetrical localization of CEP

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomePhotoreceptor inner segmentCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasm, cytoskeleton, cilium basal body

MECANISMO DE DOENÇA

Joubert syndrome 23

A mild form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
16.6 TPM
Linfócitos
8.7 TPM
Cérebro - Hemisfério cerebelar
7.1 TPM
Cerebelo
6.7 TPM
Fibroblastos
6.4 TPM
OUTRAS DOENÇAS (4)
Joubert syndrome 23short-rib thoracic dysplasia 14 with polydactylyJoubert syndromeJoubert syndrome with Jeune asphyxiating thoracic dystrophy
HGNC:19960UniProt:Q9BVV6
STUB1E3 ubiquitin-protein ligase CHIPDisease-causing germline mutation(s) inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase which targets misfolded chaperone substrates towards proteasomal degradation (PubMed:10330192, PubMed:11146632, PubMed:11557750, PubMed:23990462, PubMed:26265139). Plays a role in the maintenance of mitochondrial morphology and promotes mitophagic removal of dysfunctional mitochondria; thereby acts as a protector against apoptosis in response to cellular stress (By similarity). Negatively regulates vascular smooth muscle contraction, via degradation of the transcripti

LOCALIZAÇÃO

CytoplasmNucleusMitochondrion

VIAS BIOLÓGICAS (8)
Downregulation of TGF-beta receptor signalingAntigen processing: Ubiquitination & Proteasome degradationRIPK1-mediated regulated necrosisRegulation of necroptotic cell deathRegulation of TNFR1 signaling
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 16

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR16 is characterized by truncal and limb ataxia resulting in gait instability. Additionally, patients may show dysarthria, nystagmus, spasticity of the lower limbs, and mild peripheral sensory neuropathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
136.1 TPM
Cerebelo
123.5 TPM
Brain Frontal Cortex BA9
121.3 TPM
Artéria tibial
109.3 TPM
Skin Sun Exposed Lower leg
108.7 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia 48autosomal recessive spinocerebellar ataxia 16
HGNC:11427UniProt:Q9UNE7
SACSSacsinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Co-chaperone which acts as a regulator of the Hsp70 chaperone machinery and may be involved in the processing of other ataxia-linked proteins

LOCALIZAÇÃO

Cytoplasm

MECANISMO DE DOENÇA

Spastic ataxia Charlevoix-Saguenay type

A neurodegenerative disease characterized by early-onset cerebellar ataxia, spasticity, retinal hypermyelination, pyramidal signs, and both axonal and demyelinating neuropathy with loss of sensory nerve conduction and reduced motor conduction velocities. Other features include dysarthria, distal muscle wasting, nystagmus, defect in conjugate pursuit ocular movements, retinal striation (from prominent retinal nerves) obscuring the retinal blood vessels in places, and the frequent presence of mitral valve prolapse.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
22.6 TPM
Linfócitos
15.5 TPM
Artéria tibial
13.4 TPM
Aorta
13.3 TPM
Artéria coronária
13.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
Charlevoix-Saguenay spastic ataxia
HGNC:10519UniProt:Q9NZJ4
SETXHelicase senataxinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

ATP-dependent 5'->3' DNA/RNA helicase that preferentially unwinds RNA substrates over DNA, playing a crucial role in resolving R-loops and promoting transcription termination (PubMed:36864660). Plays a role in transcription regulation by its ability to modulate RNA Polymerase II (Pol II) binding to chromatin and through its interaction with proteins involved in transcription (PubMed:19515850, PubMed:21700224). Contributes to the mRNA splicing efficiency and splice site selection (PubMed:19515850

LOCALIZAÇÃO

NucleusNucleus, nucleoplasmNucleus, nucleolusCytoplasmChromosomeChromosome, telomereCell projection, axonCell projection, growth cone

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAN2 is an autosomal recessive form associated with peripheral neuropathy and elevated serum alpha-fetoprotein, immunoglobulins and, less commonly, creatine kinase levels. Some SCAN2 patients manifest oculomotor apraxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
50.4 TPM
Linfócitos
39.4 TPM
Tireoide
36.1 TPM
Baço
32.8 TPM
Pulmão
25.9 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2amyotrophic lateral sclerosis type 4
HGNC:445UniProt:Q7Z333
CYP27A1Sterol 26-hydroxylase, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Cytochrome P450 monooxygenase that catalyzes regio- and stereospecific hydroxylation of cholesterol and its derivatives. Hydroxylates (with R stereochemistry) the terminal methyl group of cholesterol side-chain in a three step reaction to yield at first a C26 alcohol, then a C26 aldehyde and finally a C26 acid (PubMed:12077124, PubMed:21411718, PubMed:28190002, PubMed:9660774). Regulates cholesterol homeostasis by catalyzing the conversion of excess cholesterol to bile acids via both the 'neutra

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Synthesis of bile acids and bile salts via 27-hydroxycholesterolEndogenous sterolsSynthesis of bile acids and bile salts via 24-hydroxycholesterolSynthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
MECANISMO DE DOENÇA

Cerebrotendinous xanthomatosis

Rare sterol storage disorder characterized clinically by progressive neurologic dysfunction, premature atherosclerosis, and cataracts.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
332.0 TPM
Nervo tibial
127.6 TPM
Pulmão
119.5 TPM
Brain Spinal cord cervical c-1
113.6 TPM
Aorta
85.9 TPM
OUTRAS DOENÇAS (1)
cerebrotendinous xanthomatosis
HGNC:2605UniProt:Q02318
VPS41Vacuolar protein sorting-associated protein 41 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in vesicle-mediated protein trafficking to lysosomal compartments including the endocytic membrane transport and autophagic pathways. Acts as a component of the HOPS endosomal tethering complex. This complex is proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The HOPS complex is proposed to be recruited to Rab7 on the

LOCALIZAÇÃO

Endosome membraneLate endosome membraneEarly endosome membraneLysosome membraneGolgi apparatus, trans-Golgi networkCytoplasmic vesicle, clathrin-coated vesicleCytoplasm, cytosol

VIAS BIOLÓGICAS (1)
SARS-CoV-2 modulates autophagy
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 29

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR29 is a progressive disease characterized by delayed motor development in early infancy followed by difficulty walking due to an ataxic gait or inability to walk, hypotonia, and variably impaired intellectual development.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
28.7 TPM
Brain Frontal Cortex BA9
28.6 TPM
Ovário
27.4 TPM
Artéria tibial
27.1 TPM
Fibroblastos
27.0 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia, autosomal recessive 29autosomal recessive cerebellar ataxia-saccadic intrusion syndrome
HGNC:12713UniProt:P49754
TWNKTwinkle mtDNA helicaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Mitochondrial helicase involved in mtDNA replication and repair (PubMed:12975372, PubMed:15167897, PubMed:17324440, PubMed:18039713, PubMed:18971204, PubMed:25824949, PubMed:26887820, PubMed:27226550). Might have a role in mtDNA repair (PubMed:27226550). Has DNA strand separation activity needed to form a processive replication fork for leading strand synthesis which is catalyzed by the formation of a replisome complex with POLG and mtSDB (PubMed:12975372, PubMed:15167897, PubMed:18039713, PubMe

LOCALIZAÇÃO

Mitochondrion matrix, mitochondrion nucleoidMitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Strand-asynchronous mitochondrial DNA replicationMitochondrial protein degradationTranscriptional activation of mitochondrial biogenesis
MECANISMO DE DOENÇA

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3

A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
21.9 TPM
Testículo
20.3 TPM
Fibroblastos
14.6 TPM
Ovário
10.6 TPM
Útero
10.3 TPM
OUTRAS DOENÇAS (8)
mitochondrial DNA depletion syndrome 7 (hepatocerebral type)Perrault syndrome 5progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3autosomal dominant progressive external ophthalmoplegia
HGNC:1160UniProt:Q96RR1
TDP2Tyrosyl-DNA phosphodiesterase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

DNA repair enzyme that can remove a variety of covalent adducts from DNA through hydrolysis of a 5'-phosphodiester bond, giving rise to DNA with a free 5' phosphate. Catalyzes the hydrolysis of dead-end complexes between DNA and the topoisomerase 2 (TOP2) active site tyrosine residue. The 5'-tyrosyl DNA phosphodiesterase activity can enable the repair of TOP2-induced DNA double-strand breaks/DSBs without the need for nuclease activity, creating a 'clean' DSB with 5'-phosphate termini that are re

LOCALIZAÇÃO

NucleusNucleus, PML bodyNucleus, nucleolusCytoplasm

VIAS BIOLÓGICAS (1)
Nonhomologous End-Joining (NHEJ)
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 23

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR23 patients manifest epilepsy, intellectual disability, and gait ataxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Intestino delgado
57.6 TPM
Cérebro - Hemisfério cerebelar
47.5 TPM
Cólon transverso
46.9 TPM
Próstata
44.4 TPM
Linfócitos
41.8 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 23
HGNC:17768UniProt:O95551
GRID2Glutamate receptor ionotropic, delta-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Member of the ionotropic glutamate receptor family, which plays a crucial role in synaptic organization and signal transduction in the central nervous system. Although it shares structural features with ionotropic glutamate receptors, does not bind glutamate as a primary ligand (PubMed:34936451). Promotes synaptogenesis and mediates the D-Serine-dependent long term depression signals and AMPA receptor endocytosis of cerebellar parallel fiber-Purkinje cell (PF-PC) synapses through the NRX1B-CBLN1

LOCALIZAÇÃO

Postsynaptic cell membrane

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 18

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR18 features include progressive cerebellar atrophy, delayed psychomotor development, severely impaired gait, ocular movement abnormalities, and intellectual disability.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
10.4 TPM
Cérebro - Hemisfério cerebelar
7.5 TPM
Testículo
6.2 TPM
Brain Nucleus accumbens basal ganglia
1.8 TPM
Hipotálamo
1.6 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 18
HGNC:4576UniProt:O43424
COQ8AAtypical kinase COQ8A, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Atypical kinase involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:21296186, PubMed:25498144, PubMed:25540914, PubMed:27499294, PubMed:36302899, PubMed:38425362). Its substrate specificity is still unclear: may act as a protein kinase that mediates phosphorylation of COQ3 (By similarity). According to other reports, acts as a small molecule kinase, possibly a lipid kinase that phosphorylates

LOCALIZAÇÃO

Mitochondrion membrane

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 4

An autosomal recessive disorder characterized by childhood-onset of cerebellar ataxia and exercise intolerance. Patient manifest gait ataxia and cerebellar atrophy with slow progression. Additional features include brisk tendon reflexes and Hoffmann sign, variable psychomotor retardation and variable seizures.

VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
autosomal recessive ataxia due to ubiquinone deficiency
HGNC:16812UniProt:Q8NI60
CEP290Centrosomal protein of 290 kDaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in early and late steps in cilia formation. Its association with CCP110 is required for inhibition of primary cilia formation by CCP110 (PubMed:18694559). May play a role in early ciliogenesis in the disappearance of centriolar satellites and in the transition of primary ciliar vesicles (PCVs) to capped ciliary vesicles (CCVs). Required for the centrosomal recruitment of RAB8A and for the targeting of centriole satellite proteins to centrosomes such as of PCM1 (PubMed:24421332). Require

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satelliteNucleusCell projection, ciliumCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasmic vesicle

VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 5

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis.

OUTRAS DOENÇAS (10)
Senior-Loken syndrome 6Leber congenital amaurosis 10Joubert syndrome 5Meckel syndrome, type 4
HGNC:29021UniProt:O15078
TMEM231Transmembrane protein 231Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transmembrane component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Required for ciliogenesis and sonic hedgehog/SHH signaling (By similarity)

LOCALIZAÇÃO

Cell projection, cilium membrane

MECANISMO DE DOENÇA

Joubert syndrome 20

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
14.2 TPM
Pituitária
13.8 TPM
Fallopian Tube
12.9 TPM
Cervix Endocervix
12.0 TPM
Útero
11.8 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 20Meckel syndrome, type 11Meckel syndromeJoubert syndrome with oculorenal defect
HGNC:37234UniProt:Q9H6L2
WDR81WD repeat-containing protein 81Candidate gene tested inTolerante
FUNÇÃO

Functions as a negative regulator of the PI3 kinase/PI3K activity associated with endosomal membranes via BECN1, a core subunit of the PI3K complex. By modifying the phosphatidylinositol 3-phosphate/PtdInsP3 content of endosomal membranes may regulate endosome fusion, recycling, sorting and early to late endosome transport (PubMed:26783301). It is for instance, required for the delivery of cargos like BST2/tetherin from early to late endosome and thereby participates indirectly to their degradat

LOCALIZAÇÃO

Early endosome membraneLate endosome membraneLysosome membraneCytoplasmic vesicle, autophagosome membraneMitochondrionCytoplasm, cytosol

VIAS BIOLÓGICAS (1)
CDC42 GTPase cycle
MECANISMO DE DOENÇA

Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 2

An autosomal recessive, congenital cerebellar ataxia associated with cerebellar hypoplasia, intellectual disability, and inability to walk bipedally, resulting in quadrupedal locomotion as a functional adaptation. Additional findings include generalized brain atrophy and mild hypoplasia of the corpus callosum.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
32.0 TPM
Cervix Endocervix
31.9 TPM
Útero
31.8 TPM
Baço
30.9 TPM
Cervix Ectocervix
27.1 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (5)
hydrocephalus, congenital, 3, with brain anomaliescerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2congenital communicating hydrocephaluscerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:26600UniProt:Q562E7
SYNE1Nesprin-1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Multi-isomeric modular protein which forms a linking network between organelles and the actin cytoskeleton to maintain the subcellular spatial organization. As a component of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex involved in the connection between the nuclear lamina and the cytoskeleton. The nucleocytoplasmic interactions established by the LINC complex play an important role in the transmission of mechanical forces across the nuclear envelope and in nuclear movement and p

LOCALIZAÇÃO

Nucleus outer membraneNucleusNucleus envelopeCytoplasm, cytoskeletonCytoplasm, myofibril, sarcomereGolgi apparatus

VIAS BIOLÓGICAS (1)
Meiotic synapsis
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 8

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR8 is an autosomal recessive form.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
64.7 TPM
Cérebro - Hemisfério cerebelar
59.5 TPM
Ovário
38.9 TPM
Aorta
30.2 TPM
Tireoide
27.1 TPM
OUTRAS DOENÇAS (5)
Emery-Dreifuss muscular dystrophy 4, autosomal dominantautosomal recessive ataxia, Beauce typearthrogryposis multiplex congenita 3, myogenic typeautosomal recessive myogenic arthrogryposis multiplex congenita
HGNC:17089UniProt:Q8NF91
ATG7Ubiquitin-like modifier-activating enzyme ATG7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E1-like activating enzyme involved in the 2 ubiquitin-like systems required for cytoplasm to vacuole transport (Cvt) and autophagy. Activates ATG12 for its conjugation with ATG5 as well as the ATG8 family proteins for their conjugation with phosphatidylethanolamine. Both systems are needed for the ATG8 association to Cvt vesicles and autophagosomes membranes. Required for autophagic death induced by caspase-8 inhibition. Facilitates LC3-I lipidation with phosphatidylethanolamine to form LC3-II w

LOCALIZAÇÃO

CytoplasmPreautophagosomal structure

VIAS BIOLÓGICAS (3)
MacroautophagyAntigen processing: Ubiquitination & Proteasome degradationDengue Virus Attachment and Entry
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 31

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR30 is characterized by global developmental delay, hypotonia, variably impaired intellectual and language development, ataxic gait, tremor, and dysarthria. Most affected individuals have optic atrophy. Additional features may include retinitis pigmentosa, sensorineural deafness, dysmorphic facial features, and possibly endocrine dysfunction.

OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 31
HGNC:HGNC:16935UniProt:O95352
GDAP2Ganglioside-induced differentiation-associated protein 2Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 27

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR27 is a progressive disease characterized by gait difficulties, eye movement abnormalities, dysarthria, and difficulty writing. Some patients may lose independent ambulation. Additional features include spasticity of the lower limbs and cognitive impairment.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
5.4 TPM
Cervix Endocervix
4.7 TPM
Pulmão
4.5 TPM
Tireoide
4.4 TPM
Cervix Ectocervix
4.2 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 27
HGNC:HGNC:18010UniProt:Q9NXN4
WWOXWW domain-containing oxidoreductaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Putative oxidoreductase. Acts as a tumor suppressor and plays a role in apoptosis. Required for normal bone development (By similarity). May function synergistically with p53/TP53 to control genotoxic stress-induced cell death. Plays a role in TGFB1 signaling and TGFB1-mediated cell death. May also play a role in tumor necrosis factor (TNF)-mediated cell death. Inhibits Wnt signaling, probably by sequestering DVL2 in the cytoplasm

LOCALIZAÇÃO

CytoplasmNucleusMitochondrionGolgi apparatusLysosome

VIAS BIOLÓGICAS (3)
Nuclear signaling by ERBB4Activation of the TFAP2 (AP-2) family of transcription factorsNegative regulation of activity of TFAP2 (AP-2) family transcription factors
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.8 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
Cerebelo
11.2 TPM
Brain Spinal cord cervical c-1
10.5 TPM
Nervo tibial
8.2 TPM
OUTRAS DOENÇAS (5)
autosomal recessive spinocerebellar ataxia 12esophageal cancerdevelopmental and epileptic encephalopathy, 28esophageal squamous cell carcinoma
HGNC:12799UniProt:Q9NZC7
MKS1Tectonic-like complex member MKS1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Involved in centrosome migration to the apical cell surface during early ciliogenesis. Required for ciliary structure and function, including a role in regulating length and appropriate number through modulating centrosome duplication. Required for cell branching morphology

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Meckel syndrome 1

A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
24.3 TPM
Ovário
22.3 TPM
Útero
20.0 TPM
Cervix Endocervix
18.8 TPM
Pituitária
18.7 TPM
OUTRAS DOENÇAS (7)
Joubert syndrome 28Bardet-Biedl syndrome 13Meckel syndrome, type 1Joubert syndrome
HGNC:7121UniProt:Q9NXB0
FXNFrataxin, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Functions as an activator of persulfide transfer to the scaffoding protein ISCU as component of the core iron-sulfur cluster (ISC) assembly complex and participates to the [2Fe-2S] cluster assembly (PubMed:12785837, PubMed:24971490). Accelerates sulfur transfer from NFS1 persulfide intermediate to ISCU and to small thiols such as L-cysteine and glutathione leading to persulfuration of these thiols and ultimately sulfide release (PubMed:24971490). Binds ferrous ion and is released from FXN upon t

LOCALIZAÇÃO

MitochondrionCytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Mitochondrial protein import
MECANISMO DE DOENÇA

Friedreich ataxia

Autosomal recessive, progressive degenerative disease characterized by neurodegeneration and cardiomyopathy it is the most common inherited ataxia. The disorder is usually manifest before adolescence and is generally characterized by incoordination of limb movements, dysarthria, nystagmus, diminished or absent tendon reflexes, Babinski sign, impairment of position and vibratory senses, scoliosis, pes cavus, and hammer toe. In most patients, FRDA is due to GAA triplet repeat expansions in the first intron of the frataxin gene. But in some cases the disease is due to mutations in the coding region.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
12.5 TPM
Linfócitos
11.2 TPM
Glândula adrenal
10.8 TPM
Fibroblastos
10.6 TPM
Útero
9.3 TPM
OUTRAS DOENÇAS (2)
Friedreich ataxia 1Friedreich ataxia
HGNC:3951UniProt:Q16595
PIK3R5Phosphoinositide 3-kinase regulatory subunit 5Candidate gene tested inAltamente restrito
FUNÇÃO

Regulatory subunit of the PI3K gamma complex. Required for recruitment of the catalytic subunit to the plasma membrane via interaction with beta-gamma G protein dimers. Required for G protein-mediated activation of PIK3CG (By similarity)

LOCALIZAÇÃO

NucleusCytoplasmCell membrane

VIAS BIOLÓGICAS (9)
PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingPIP3 activates AKT signalingConstitutive Signaling by Aberrant PI3K in CancerCD28 dependent PI3K/Akt signalingCo-stimulation by ICOS
MECANISMO DE DOENÇA

Ataxia-oculomotor apraxia 3

An autosomal recessive disease characterized by cerebellar ataxia, oculomotor apraxia, areflexia and peripheral neuropathy.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
59.9 TPM
Baço
40.8 TPM
Linfócitos
34.7 TPM
Pulmão
26.5 TPM
Intestino delgado
10.4 TPM
OUTRAS DOENÇAS (2)
ataxia with oculomotor apraxia type 3spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
HGNC:30035UniProt:Q8WYR1
UBA5Ubiquitin-like modifier-activating enzyme 5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E1-like enzyme which specifically catalyzes the first step in ufmylation (PubMed:15071506, PubMed:18442052, PubMed:20368332, PubMed:25219498, PubMed:26929408, PubMed:27545674, PubMed:27545681, PubMed:27653677, PubMed:30412706, PubMed:30626644, PubMed:34588452). Activates UFM1 by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a UFM1-E1 thioester and free AMP (PubMed:20368332, PubMed:26929408, P

LOCALIZAÇÃO

CytoplasmNucleusEndoplasmic reticulum membraneGolgi apparatus

VIAS BIOLÓGICAS (2)
Antigen processing: Ubiquitination & Proteasome degradationDengue Virus Attachment and Entry
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 44

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE44 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
53.3 TPM
Linfócitos
40.4 TPM
Tireoide
37.8 TPM
Glândula adrenal
36.8 TPM
Próstata
36.3 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia, autosomal recessive 24developmental and epileptic encephalopathy, 44undetermined early-onset epileptic encephalopathy
HGNC:23230UniProt:Q9GZZ9
CC2D2ACoiled-coil and C2 domain-containing protein 2ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Required for ciliogenesis and sonic hedgehog/SHH signaling (By similarity)

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Meckel syndrome 6

A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.

OUTRAS DOENÇAS (8)
retinitis pigmentosa 93COACH syndrome 2Joubert syndrome 9Meckel syndrome, type 6
HGNC:29253UniProt:Q9P2K1
RPGRIP1LProtein fantomDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Negatively regulates signaling through the G-protein coupled thromboxane A2 receptor (TBXA2R) (PubMed:19464661). May be involved in mechanisms like programmed cell death, craniofacial development, patterning of the limbs, and formation of the left-right axis (By similarity). Involved in the organization of apical junctions; the function is proposed to implicate a NPHP1-4-8 module. Does not seem to be strictly required for ciliogenesis (PubMed:19464661). Involved in establishment of planar cell p

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton, cilium basal bodyCytoplasm, cytoskeleton, cilium axonemeCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell junction, tight junction

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.1 TPM
Fibroblastos
7.3 TPM
Pituitária
5.6 TPM
Ovário
3.0 TPM
Cervix Endocervix
3.0 TPM
OUTRAS DOENÇAS (6)
Meckel syndrome, type 5Joubert syndrome 7COACH syndrome 3COACH syndrome
HGNC:29168UniProt:Q68CZ1
XRCC1DNA repair protein XRCC1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Scaffold protein involved in DNA single-strand break repair by mediating the assembly of DNA break repair protein complexes (PubMed:11163244, PubMed:28002403). Negatively regulates ADP-ribosyltransferase activity of PARP1 during base-excision repair in order to prevent excessive PARP1 activity (PubMed:28002403, PubMed:34102106, PubMed:34811483). Recognizes and binds poly-ADP-ribose chains: specifically binds auto-poly-ADP-ribosylated PARP1, limiting its activity (PubMed:14500814, PubMed:34102106

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (5)
HDR through MMEJ (alt-NHEJ)Gap-filling DNA repair synthesis and ligation in TC-NERGap-filling DNA repair synthesis and ligation in GG-NERAPEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement PathwayResolution of AP sites via the single-nucleotide replacement pathway
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 26

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR26 is a progressive disease characterized by gait and limb ataxia, loss of independent ambulation, oculomotor apraxia, and peripheral neuropathy with distal muscle weakness and areflexia.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
55.0 TPM
Ovário
49.3 TPM
Cervix Ectocervix
47.6 TPM
Testículo
47.3 TPM
Útero
46.9 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive 26
HGNC:HGNC:12828UniProt:P18887
PEX10Peroxisome biogenesis factor 10Candidate gene tested inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase component of a retrotranslocation channel required for peroxisome organization by mediating export of the PEX5 receptor from peroxisomes to the cytosol, thereby promoting PEX5 recycling (PubMed:24662292). The retrotranslocation channel is composed of PEX2, PEX10 and PEX12; each subunit contributing transmembrane segments that coassemble into an open channel that specifically allows the passage of PEX5 through the peroxisomal membrane (By similarity). PEX10 also regula

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (2)
Peroxisomal protein importE3 ubiquitin ligases ubiquitinate target proteins
MECANISMO DE DOENÇA

Peroxisome biogenesis disorder complementation group 7

A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
33.5 TPM
Glândula adrenal
23.3 TPM
Brain Spinal cord cervical c-1
22.1 TPM
Nervo tibial
20.8 TPM
Fibroblastos
20.1 TPM
OUTRAS DOENÇAS (5)
peroxisome biogenesis disorder 6Bperoxisome biogenesis disorder 6A (Zellweger)autosomal recessive ataxia due to PEX10 deficiencyZellweger spectrum disorders
HGNC:8851UniProt:O60683
TMEM67MeckelinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for ciliary structure and function. Part of the tectonic-like complex which is required for tissue-specific ciliogenesis and may regulate ciliary membrane composition (By similarity). Involved in centrosome migration to the apical cell surface during early ciliogenesis. Involved in the regulation of cilia length and appropriate number through the control of centrosome duplication. Is a key regulator of stereociliary bundle orientation (By similarity). Required for epithelial cell branch

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneCell projection, ciliumCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
16.4 TPM
Pituitária
12.7 TPM
Tireoide
10.9 TPM
Ovário
9.9 TPM
Cervix Endocervix
9.0 TPM
OUTRAS DOENÇAS (10)
Joubert syndrome 6Meckel syndrome, type 3nephronophthisis 11COACH syndrome 1
HGNC:28396UniProt:Q5HYA8
RFC1Replication factor C subunit 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Subunit of the replication factor C (RFC) complex which acts during elongation of primed DNA templates by DNA polymerases delta and epsilon, and is necessary for ATP-dependent loading of proliferating cell nuclear antigen (PCNA) onto primed DNA (PubMed:9488738). This subunit binds to the primer-template junction. Binds the PO-B transcription element as well as other GA rich DNA sequences. Can bind single- or double-stranded DNA

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (10)
HDR through Homologous Recombination (HRR)PCNA-Dependent Long Patch Base Excision RepairRecognition of DNA damage by PCNA-containing replication complexTermination of translesion DNA synthesisTranslesion synthesis by POLK
MECANISMO DE DOENÇA

Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome

An autosomal recessive neurologic disease characterized by imbalance, cerebellar ataxia, impaired vestibular function, and non-length-dependent sensory deficit.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
49.1 TPM
Ovário
34.9 TPM
Útero
32.5 TPM
Fibroblastos
30.7 TPM
Cervix Ectocervix
30.3 TPM
OUTRAS DOENÇAS (1)
cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
HGNC:9969UniProt:P35251
PNKPBifunctional polynucleotide phosphatase/kinaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a key role in the repair of DNA damage, functioning as part of both the non-homologous end-joining (NHEJ) and base excision repair (BER) pathways (PubMed:10446192, PubMed:10446193, PubMed:15385968, PubMed:20852255, PubMed:28453785). Through its two catalytic activities, PNK ensures that DNA termini are compatible with extension and ligation by either removing 3'-phosphates from, or by phosphorylating 5'-hydroxyl groups on, the ribose sugar of the DNA backbone (PubMed:10446192, PubMed:10446

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (1)
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway
MECANISMO DE DOENÇA

Microcephaly, seizures, and developmental delay

An autosomal recessive neurodevelopmental disorder characterized by infantile-onset seizures, microcephaly, severe intellectual disability and delayed motor milestones with absent speech or only achieving a few words. Most patients also have behavioral problems with hyperactivity. Microcephaly is progressive and without neuronal migration or structural abnormalities, consistent with primary microcephaly.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
66.8 TPM
Tireoide
63.9 TPM
Baço
59.2 TPM
Glândula adrenal
55.9 TPM
Cervix Endocervix
51.8 TPM
OUTRAS DOENÇAS (4)
microcephaly, seizures, and developmental delayataxia - oculomotor apraxia type 4Charcot-Marie-Tooth disease type 2B2early-infantile DEE
HGNC:9154UniProt:Q96T60
CA8Carbonic anhydrase-related proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Does not have a carbonic anhydrase catalytic activity

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 34

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR34 is characterized by congenital cerebellar ataxia associated with dysarthia, quadrupedal gait and intellectual disability.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3cerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:1382UniProt:P35219
CSPP1Centrosome and spindle pole-associated protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May play a role in cell-cycle-dependent microtubule organization

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, spindle poleCell projection, cilium

MECANISMO DE DOENÇA

Joubert syndrome 21

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
24.0 TPM
Cérebro - Hemisfério cerebelar
10.9 TPM
Fallopian Tube
9.5 TPM
Cervix Endocervix
9.5 TPM
Ovário
9.4 TPM
OUTRAS DOENÇAS (4)
Joubert syndrome 21Joubert syndromeJoubert syndrome with Jeune asphyxiating thoracic dystrophyMeckel syndrome
HGNC:26193UniProt:Q1MSJ5
TMEM237Transmembrane protein 237Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the transition zone in primary cilia. Required for ciliogenesis

LOCALIZAÇÃO

MembraneCell projection, cilium

MECANISMO DE DOENÇA

Joubert syndrome 14

An autosomal recessive disorder characterized by severe intellectual disability, hypotonia, breathing abnormalities in infancy, and dysmorphic facial features. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include renal disease, abnormal eye movements, and postaxial polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
30.8 TPM
Skin Not Sun Exposed Suprapubic
24.6 TPM
Skin Sun Exposed Lower leg
22.7 TPM
Artéria tibial
20.4 TPM
Cérebro - Hemisfério cerebelar
18.9 TPM
OUTRAS DOENÇAS (5)
Joubert syndrome 14Meckel syndromeJoubert syndrome with oculorenal defectJoubert syndrome
HGNC:14432UniProt:Q96Q45
RNF168E3 ubiquitin-protein ligase RNF168Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase required for accumulation of repair proteins to sites of DNA damage. Acts with UBE2N/UBC13 to amplify the RNF8-dependent histone ubiquitination. Recruited to sites of DNA damage at double-strand breaks (DSBs) by binding to ubiquitinated histone H2A and H2AX and amplifies the RNF8-dependent H2A ubiquitination, promoting the formation of 'Lys-63'-linked ubiquitin conjugates. This leads to concentrate ubiquitinated histones H2A and H2AX at DNA lesions to the threshold re

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (5)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaksG2/M DNA damage checkpointProcessing of DNA double-strand break endsNonhomologous End-Joining (NHEJ)SUMOylation of DNA damage response and repair proteins
MECANISMO DE DOENÇA

Riddle syndrome

An autosomal recessive disorder characterized by increased radiosensitivity, immunodeficiency, mild motor control and learning difficulties, facial dysmorphism, and short stature.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
45.1 TPM
Linfócitos
29.6 TPM
Skin Sun Exposed Lower leg
20.0 TPM
Cervix Ectocervix
19.6 TPM
Skin Not Sun Exposed Suprapubic
18.6 TPM
OUTRAS DOENÇAS (1)
RIDDLE syndrome
HGNC:26661UniProt:Q8IYW5
TDP1Tyrosyl-DNA phosphodiesterase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

DNA repair enzyme that can remove a variety of covalent adducts from DNA through hydrolysis of a 3'-phosphodiester bond, giving rise to DNA with a free 3' phosphate. Catalyzes the hydrolysis of dead-end complexes between DNA and the topoisomerase I active site tyrosine residue. Hydrolyzes 3'-phosphoglycolates on protruding 3' ends on DNA double-strand breaks due to DNA damage by radiation and free radicals. Acts on blunt-ended double-strand DNA breaks and on single-stranded DNA. Has low 3'exonuc

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Nonhomologous End-Joining (NHEJ)
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAN1 is an autosomal recessive cerebellar ataxia (ARCA) associated with peripheral axonal motor and sensory neuropathy, distal muscular atrophy, pes cavus and steppage gait as seen in Charcot-Marie-Tooth neuropathy. All affected individuals have normal intelligence.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
25.2 TPM
Testículo
23.2 TPM
Fibroblastos
7.4 TPM
Baço
7.3 TPM
Cérebro - Hemisfério cerebelar
6.8 TPM
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1
HGNC:18884UniProt:Q9NUW8
TMEM216Transmembrane protein 216Candidate gene tested inTolerante
FUNÇÃO

Essential for primary ciliogenesis and embryonic development, facilitating the activation of Hedgehog (Hh) signaling pathway. Disrupts the interaction of GLI2 and GLI3 with the negative regulator SUFU. Inhibiting SUFU's interaction with GLI2 promotes the entry of GLI2 into the nucleus, allowing it to activate Hh target gene expression. Disrupting SUFU's interaction with GLI3 prevents its conversion into the repressor form, leading to increased nuclear GLI3 and enhanced Hh signaling. Required for

LOCALIZAÇÃO

MembraneCytoplasm, cytoskeleton, cilium basal body

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 2

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
31.3 TPM
Pituitária
27.0 TPM
Cervix Endocervix
25.9 TPM
Cervix Ectocervix
24.7 TPM
Testículo
23.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 98Meckel syndrome, type 2Joubert syndrome 2Meckel syndrome
HGNC:25018UniProt:Q9P0N5
CWF19L1CWF19-like protein 1Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 17

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR17 features include non-progressive congenital cerebellar ataxia, mildly delayed walking with an unsteady gait and frequent falls, dysarthria, dysmetria, hypotonia in the extremities, truncal ataxia, increased reflexes in the lower extremities, and intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
29.1 TPM
Linfócitos
25.6 TPM
Baço
21.8 TPM
Cérebro - Hemisfério cerebelar
21.5 TPM
Nervo tibial
19.5 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 17
HGNC:25613UniProt:Q69YN2
RUBCNRun domain Beclin-1-interacting and cysteine-rich domain-containing proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Inhibits PIK3C3 activity; under basal conditions negatively regulates PI3K complex II (PI3KC3-C2) function in autophagy. Negatively regulates endosome maturation and degradative endocytic trafficking and impairs autophagosome maturation process. Can sequester UVRAG from association with a class C Vps complex (possibly the HOPS complex) and negatively regulates Rab7 activation (PubMed:20974968, PubMed:21062745) Involved in regulation of pathogen-specific host defense of activated macrophages. Fol

LOCALIZAÇÃO

Late endosomeLysosomeEarly endosome

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 15

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR15 patients manifest cerebellar ataxia in early childhood and delayed motor development with delayed walking. Additional features include dysarthria, upper limb involvement, abnormal eye movements, and hyporeflexia.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
38.4 TPM
Cérebro - Hemisfério cerebelar
34.0 TPM
Cerebelo
30.9 TPM
Testículo
27.1 TPM
Baço
26.4 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 15
HGNC:28991UniProt:Q92622
SPTBN2Spectrin beta chain, non-erythrocytic 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Probably plays an important role in neuronal membrane skeleton

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cell cortex

VIAS BIOLÓGICAS (5)
RAF/MAP kinase cascadeNCAM signaling for neurite out-growthCOPI-mediated anterograde transportInteraction between L1 and AnkyrinsMHC class II antigen presentation
MECANISMO DE DOENÇA

Spinocerebellar ataxia 5

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA5 is an autosomal dominant cerebellar ataxia (ADCA). It is a slowly progressive disorder with variable age at onset, ranging between 10 and 50 years.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
153.6 TPM
Skin Sun Exposed Lower leg
116.8 TPM
Cérebro - Hemisfério cerebelar
113.8 TPM
Testículo
110.1 TPM
Skin Not Sun Exposed Suprapubic
102.0 TPM
OUTRAS DOENÇAS (2)
spinocerebellar ataxia type 5autosomal recessive spinocerebellar ataxia 14
HGNC:11276UniProt:O15020
SNX14Sorting nexin-14Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in maintaining normal neuronal excitability and synaptic transmission. May be involved in several stages of intracellular trafficking (By similarity). Required for autophagosome clearance, possibly by mediating the fusion of lysosomes with autophagosomes (Probable). Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), a key component of late endosomes/lysosomes (PubMed:25848753). Does not bind phosphatidylinositol 3-phosphate (PtdIns(3P)) (PubMed:25148684, PubMed:25848753)

LOCALIZAÇÃO

Lysosome membraneLate endosome membraneCell projection, dendrite

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 20

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR20 is characterized by cerebellar atrophy, ataxia, coarsened facial features, severely delayed psychomotor development with poor or absent speech, and intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
58.2 TPM
Fibroblastos
33.8 TPM
Tireoide
33.7 TPM
Cérebro - Hemisfério cerebelar
32.0 TPM
Linfócitos
31.4 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 20
HGNC:14977UniProt:Q9Y5W7
ATP8A2Phospholipid-transporting ATPase IBCandidate gene tested inTolerante
FUNÇÃO

Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids (By similarity). Able to translocate phosphatidylserine, but not phosphatidylcholine (PubMed:34403372). Phospholipid translocation also seems to be implicated in vesicle formation and in uptake of lipid signaling molecules (By similar

LOCALIZAÇÃO

MembraneGolgi apparatus membraneEndosome membraneCell membranePhotoreceptor outer segment membranePhotoreceptor inner segment membrane

VIAS BIOLÓGICAS (1)
Ion transport by P-type ATPases
MECANISMO DE DOENÇA

Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4

An autosomal recessive, congenital cerebellar ataxia associated with dysarthia, quadrupedal gait and intellectual disability.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4cerebellar ataxia, intellectual disability, and dysequilibrium
HGNC:13533UniProt:Q9NTI2
COA7Cytochrome c oxidase assembly factor 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for assembly of mitochondrial respiratory chain complex I and complex IV

LOCALIZAÇÃO

Mitochondrion intermembrane space

MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAN3 is an autosomal recessive disorder characterized by onset in the first decade of slowly progressive distal muscle weakness and atrophy and distal sensory impairment due to an axonal peripheral neuropathy. Affected individuals have gait disturbances and sometimes manual dexterity difficulties, as well as cerebellar ataxia associated with cerebellar atrophy on brain imaging.

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3
HGNC:HGNC:25716UniProt:Q96BR5
MTTPMicrosomal triglyceride transfer protein large subunitCandidate gene tested inTolerante
FUNÇÃO

Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid between phospholipid surfaces (PubMed:15897609, PubMed:16478722, PubMed:22236406, PubMed:23475612, PubMed:25108285, PubMed:26224785, PubMed:8876250, PubMed:8939939). Required for the assembly and secretion of plasma lipoproteins that contain apolipoprotein B (PubMed:16478722, PubMed:23475612, PubMed:26224785, PubMed:8876250, PubMed:8939939). May be involved in regulating cholesteryl ester biosynthesis in cells that prod

LOCALIZAÇÃO

Endoplasmic reticulumGolgi apparatus

VIAS BIOLÓGICAS (3)
VLDL assemblyChylomicron assemblyLDL remodeling
MECANISMO DE DOENÇA

Abetalipoproteinemia

An autosomal recessive disorder of lipoprotein metabolism. Affected individuals produce virtually no circulating apolipoprotein B-containing lipoproteins (chylomicrons, VLDL, LDL, lipoprotein(A)). Malabsorption of the antioxidant vitamin E occurs, leading to spinocerebellar and retinal degeneration.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
31.1 TPM
Intestino delgado
24.7 TPM
Testículo
7.1 TPM
Ovário
1.8 TPM
Linfócitos
1.2 TPM
OUTRAS DOENÇAS (1)
abetalipoproteinemia
HGNC:7467UniProt:P55157
TMEM138Transmembrane protein 138Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for ciliogenesis

LOCALIZAÇÃO

Vacuole membraneCell projection, cilium

MECANISMO DE DOENÇA

Joubert syndrome 16

An autosomal recessive disorder characterized by oculomotor apraxia, variable coloboma, and rare kidney involvement. Neuroradiologically, it is characterized by an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and polydactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
46.1 TPM
Ovário
37.6 TPM
Fallopian Tube
34.8 TPM
Útero
32.5 TPM
Cervix Endocervix
31.2 TPM
OUTRAS DOENÇAS (2)
Joubert syndrome 16Joubert syndrome with oculorenal defect
HGNC:26944UniProt:Q9NPI0
PMPCAMitochondrial-processing peptidase subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Substrate recognition and binding subunit of the essential mitochondrial processing protease (MPP), which cleaves the mitochondrial sequence off newly imported precursors proteins

LOCALIZAÇÃO

Mitochondrion matrixMitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Mitochondrial protein importProcessing of SMDT1Mitochondrial protein degradation
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 2

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR2 is characterized by onset of impaired motor development and ataxic gait in early childhood. Additional features often include loss of fine motor skills, dysarthria, nystagmus, cerebellar signs, and delayed cognitive development with intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
65.9 TPM
Testículo
61.0 TPM
Fibroblastos
58.4 TPM
Glândula adrenal
52.2 TPM
Nervo tibial
50.4 TPM
OUTRAS DOENÇAS (1)
autosomal recessive spinocerebellar ataxia 2
HGNC:18667UniProt:Q10713
ATCAYCaytaxinCandidate gene tested inTolerante
FUNÇÃO

Functions in the development of neural tissues, particularly the postnatal maturation of the cerebellar cortex. May play a role in neurotransmission through regulation of glutaminase/GLS, an enzyme responsible for the production in neurons of the glutamate neurotransmitter. Alternatively, may regulate the localization of mitochondria within axons and dendrites

LOCALIZAÇÃO

Cell projection, axonCell projection, dendritePresynapseMitochondrionCell projection, growth coneCytoplasm

MECANISMO DE DOENÇA

Cerebellar ataxia, cayman type

Found in a population isolate on Grand Cayman Island and causes a marked psychomotor retardation and prominent nonprogressive cerebellar dysfunction including nystagmus, intention tremor, dysarthria, and wide-based ataxic gait. Hypotonia is present from early childhood.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
Cayman type cerebellar ataxia
HGNC:779UniProt:Q86WG3
GRM1Metabotropic glutamate receptor 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system. May participate in the central action of glutamate in the CNS, such as long-term potentiation in the hippocampus and long-term depression in the cerebellum (PubMed:24603153, PubMed:28886343, PubMed:7476890).

LOCALIZAÇÃO

Cell membranePostsynaptic cell membraneCell projection, dendrite

VIAS BIOLÓGICAS (3)
G alpha (q) signalling eventsClass C/3 (Metabotropic glutamate/pheromone receptors)Neurexins and neuroligins
MECANISMO DE DOENÇA

Spinocerebellar ataxia, autosomal recessive, 13

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR13 is characterized by delayed psychomotor development beginning in infancy. Affected individuals show mild to profound intellectual disability with poor or absent speech as well as gait and stance ataxia and hyperreflexia.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
38.4 TPM
Cerebelo
30.6 TPM
Brain Frontal Cortex BA9
5.7 TPM
Córtex cerebral
3.6 TPM
Brain Anterior cingulate cortex BA24
3.6 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia 44autosomal recessive spinocerebellar ataxia 13chondromyxoid fibroma
HGNC:4593UniProt:Q13255
RNU12Candidate gene tested inDesconhecido
LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
RNA polymerase II transcribes snRNA genes
OUTRAS DOENÇAS (3)
craniosynostosis-anal anomalies-porokeratosis syndromespinocerebellar ataxia, autosomal recessive 33congenital cerebellar ataxia due to RNU12 mutation
HGNC:19380
AHI1JouberinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in vesicle trafficking and required for ciliogenesis, formation of primary non-motile cilium, and recruitment of RAB8A to the basal body of primary cilium. Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Involved in neuronal differentiation. As a positive modulator of classical Wnt signaling, may play a crucial role in cili

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, cilium basal bodyCell junction, adherens junctionCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole

VIAS BIOLÓGICAS (1)
Anchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Joubert syndrome 3

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 3 shows minimal extra central nervous system involvement and appears not to be associated with renal dysfunction.

OUTRAS DOENÇAS (4)
Joubert syndrome 3Joubert syndromeretinitis pigmentosaJoubert syndrome with ocular defect
HGNC:21575UniProt:Q8N157

Medicamentos e terapias

CHENODIOLPhase 4

Mecanismo: Bile acid receptor FXR agonist

OMAVELOXOLONEPhase 4

Mecanismo: Nuclear factor erythroid 2-related factor 2 activator

VATIQUINONEPhase 3

Mecanismo: Quinone reductase 1 modulator

PIOGLITAZONEPhase 3

Mecanismo: Peroxisome proliferator-activated receptor gamma agonist

INTERFERON GAMMA-1BPhase 3

Mecanismo: Interferon gamma receptor agonist

LOVASTATINPhase 2

Mecanismo: HMG-CoA reductase inhibitor

VARENICLINEPhase 2

Mecanismo: Neuronal acetylcholine receptor; alpha4/beta2 partial agonist

LERIGLITAZONEPhase 2

Mecanismo: Peroxisome proliferator-activated receptor gamma agonist

EPOETIN ALFAPhase 2

Mecanismo: Erythropoietin receptor agonist

ROSUVASTATINPhase 0.5

Mecanismo: HMG-CoA reductase inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

1,334 variantes patogênicas registradas no ClinVar.

🧬 POLG: NM_002693.3(POLG):c.2157+2T>C ()
🧬 POLG: NM_002693.3(POLG):c.1315C>T (p.Gln439Ter) ()
🧬 POLG: NM_002693.3(POLG):c.2669A>G (p.Asp890Gly) ()
🧬 POLG: NM_002693.3(POLG):c.2342C>A (p.Ala781Asp) ()
🧬 POLG: NM_002693.3(POLG):c.2421dup (p.Ile808fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 166 variantes classificadas pelo ClinVar.

83
83
Patogênica (50.0%)
VUS (50.0%)
VARIANTES MAIS SIGNIFICATIVAS
VPS13D: NM_015378.4(VPS13D):c.12424del (p.Ser4142fs) [Likely pathogenic]
VPS13D: NM_015378.4(VPS13D):c.3943C>T (p.Arg1315Ter) [Likely pathogenic]
VPS13D: NM_015378.4(VPS13D):c.1212+1G>C [Likely pathogenic]
VPS13D: NM_015378.4(VPS13D):c.9301C>T (p.Arg3101Trp) [Likely pathogenic]
VPS13D: NM_015378.4(VPS13D):c.12794+1G>T [Likely pathogenic]

Vias biológicas (Reactome)

142 vias biológicas associadas aos genes desta condição.

Strand-asynchronous mitochondrial DNA replication Reelin signalling pathway VLDLR internalisation and degradation VLDL clearance Formation of RNA Pol II elongation complex Formation of the Early Elongation Complex Formation of HIV elongation complex in the absence of HIV Tat Formation of the HIV-1 Early Elongation Complex Formation of HIV-1 elongation complex containing HIV-1 Tat Pausing and recovery of Tat-mediated HIV elongation Abortive elongation of HIV-1 transcript in the absence of Tat Tat-mediated HIV elongation arrest and recovery Tat-mediated elongation of the HIV-1 transcript HIV elongation arrest and recovery Pausing and recovery of HIV elongation RNA Polymerase II Pre-transcription Events TP53 Regulates Transcription of DNA Repair Genes RNA Polymerase II Transcription Elongation Translocation of SLC2A4 (GLUT4) to the plasma membrane Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane Gap junction assembly MHC class II antigen presentation Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Recruitment of NuMA to mitotic centrosomes Prefoldin mediated transfer of substrate to CCT/TriC Formation of tubulin folding intermediates by CCT/TriC Post-chaperonin tubulin folding pathway Recycling pathway of L1 Hedgehog 'off' state Cargo trafficking to the periciliary membrane Intraflagellar transport RHO GTPases activate IQGAPs RHO GTPases Activate Formins COPI-mediated anterograde transport COPI-dependent Golgi-to-ER retrograde traffic COPI-independent Golgi-to-ER retrograde traffic Mitotic Prometaphase The role of GTSE1 in G2/M progression after G2 checkpoint Carboxyterminal post-translational modifications of tubulin HCMV Early Events Assembly and cell surface presentation of NMDA receptors Activation of AMPK downstream of NMDARs Aggrephagy EML4 and NUDC in mitotic spindle formation Sealing of the nuclear envelope (NE) by ESCRT-III Kinesins Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 Mitochondrial protein import XBP1(S) activates chaperone genes Detoxification of Reactive Oxygen Species Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Anchoring of the basal body to the plasma membrane AURKA Activation by TPX2 Stimuli-sensing channels Induction of Cell-Cell Fusion Peroxisomal protein import Heme biosynthesis Iron uptake and transport Hyaluronan degradation Sodium/Proton exchangers tRNA modification in the nucleus and cytosol Downregulation of TGF-beta receptor signaling RIPK1-mediated regulated necrosis Regulation of TNFR1 signaling Regulation of necroptotic cell death Downregulation of ERBB2 signaling Regulation of RUNX2 expression and activity Regulation of PTEN stability and activity Antigen processing: Ubiquitination & Proteasome degradation Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol Synthesis of bile acids and bile salts via 24-hydroxycholesterol Synthesis of bile acids and bile salts via 27-hydroxycholesterol Endogenous sterols Defective CYP27A1 causes CTX SARS-CoV-2 modulates autophagy Transcriptional activation of mitochondrial biogenesis Mitochondrial protein degradation Nonhomologous End-Joining (NHEJ) Ubiquinol biosynthesis Neutrophil degranulation CDC42 GTPase cycle Meiotic synapsis Macroautophagy Signaling by BRAF and RAF1 fusions Dengue Virus Attachment and Entry Nuclear signaling by ERBB4 Negative regulation of activity of TFAP2 (AP-2) family transcription factors Activation of the TFAP2 (AP-2) family of transcription factors Mitochondrial iron-sulfur cluster biogenesis Maturation of TCA enzymes and regulation of TCA cycle Complex III assembly GPVI-mediated activation cascade PIP3 activates AKT signaling Synthesis of PIPs at the plasma membrane Constitutive Signaling by Aberrant PI3K in Cancer CD28 dependent PI3K/Akt signaling G beta:gamma signalling through PI3Kgamma PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Erythropoietin activates Phosphoinositide-3-kinase (PI3K) Co-stimulation by ICOS Resolution of AP sites via the single-nucleotide replacement pathway APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway HDR through MMEJ (alt-NHEJ) Gap-filling DNA repair synthesis and ligation in GG-NER Gap-filling DNA repair synthesis and ligation in TC-NER E3 ubiquitin ligases ubiquitinate target proteins Translesion synthesis by REV1 Recognition of DNA damage by PCNA-containing replication complex Translesion Synthesis by POLH Polymerase switching on the C-strand of the telomere PCNA-Dependent Long Patch Base Excision Repair Translesion synthesis by POLK Translesion synthesis by POLI Termination of translesion DNA synthesis HDR through Homologous Recombination (HRR) Dual Incision in GG-NER Dual incision in TC-NER Polymerase switching SUMOylation of DNA damage response and repair proteins Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Processing of DNA double-strand break ends G2/M DNA damage checkpoint NCAM signaling for neurite out-growth Interaction between L1 and Ankyrins RAF/MAP kinase cascade Ion transport by P-type ATPases VLDL assembly Chylomicron assembly LDL remodeling Processing of SMDT1 G alpha (q) signalling events Class C/3 (Metabotropic glutamate/pheromone receptors) Neurexins and neuroligins Sensory perception of sweet, bitter, and umami (glutamate) taste RNU12 gene U12 snRNA U1,U2,U4,U4atac,U5,U11,U12 gene

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado2
3Fase 33
2Fase 25
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 3 ensaios
✓ Aprovados — podem ser usados hoje
CHENODIOLOMAVELOXOLONE
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Ataxia cerebelosa autossômica recessiva

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

3 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
119 papers (10 anos)
#1

Multisystemic Involvement in Autosomal Recessive Cerebellar Ataxia Type 8 Having a Novel SYNE1 Nonsense Variant.

Internal medicine (Tokyo, Japan)2026 Mar 17

Autosomal recessive cerebellar ataxia type 8 (SCAR8) is a neurodegenerative disorder caused by variants of the SYNE1 gene. It presents with progressive cerebellar ataxia, and some patients exhibit multisystemic symptoms. A 33-year-old woman had cerebellar ataxia since childhood, motor neuron disease, vocal cord abduction paralysis, joint deformities, oculocutaneous telangiectasia, and obesity, and required a tracheostomy. Whole-exome sequencing revealed compound heterozygous nonsense variants of SYNE1 (NM_033071.5), including the novel variant c.18727C>T (p.Gln6243Ter). The SYNE1 mRNA expression was reduced by 23% relative to that in the controls. A literature review, including this case, revealed that SYNE1 variants tend to cluster in the C-terminal region in patients with respiratory dysfunction.

#2

Juvenile-Onset Cerebrotendinous Xanthomatosis with Novel Compound Heterozygous CYP27A1 Mutations: Case Series and Literature Review.

Cerebellum (London, England)2026 Jan 13

Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive neurometabolic disorder characterized by multisystem involvement and marked clinical heterogeneity. Pathogenic variants in the CYP27A1 gene, encoding mitochondrial sterol-27-hydroxylase, disrupt bile acid synthesis, leading to pathological accumulation of cholestanol in neural tissues, tendons, and other organs. This study aimed to characterize two novel CTX cases with compound heterozygous variants in the CYP27A1 gene through integrated clinical-genetic analysis, and to systematically synthesize current evidence on CTX through a literature review. Molecular investigations employed a tiered sequencing strategy: whole-exome sequencing (WES) for variant discovery, third-generation sequencing for variant screening of WES-negative samples, and Sanger sequencing for familial segregation validation. We present two Chinese juvenile-onset CTX cases demonstrating characteristic multisystem involvement, including both extraneural manifestations and progressive neurological deterioration. Genetic investigations revealed three CYP27A1 variants: the previously unreported c.845 - 46_881del83, the splicing variant c.1477-2 A > C, and a novel nonsense variant c.487 C > T in exon 3. Both probands exhibited compound heterozygosity, sharing the c.845 - 46_881del83 variant alongside distinct second alleles (c.1477-2 A > C and c.487 C > T, respectively). Then, a literature review synthesizes current evidence on clinical manifestations, genotypic patterns, and therapeutic approaches in CTX. This study expands the CYP27A1 mutational spectrum with two novel variants and validates the diagnostic utility of long-read sequencing (LRS) in resolving complex autosomal recessive cerebellar ataxia (ARCA) cases. The synthesis of clinical and literature evidence underscores the need for early recognition of CTX's heterogeneous presentations.

#3

Natural history of SPTBN4-related neurodevelopmental disorder with hypotonia, neuropathy, and deafness.

Orphanet journal of rare diseases2025 Aug 08

Pathogenic variants in SPTBN4 have been linked to autosomal recessive "neurodevelopmental disorder with hypotonia, neuropathy, and deafness" (MIM# 617519) known as NEDHND. The disorder is highlighted with neuropathy, muscle weakness, and infrequent appearance of seizures in the affected individuals. This study aims to investigate the natural history of the disease, present genetic and clinical appearance of the syndrome in a highly consanguineous population, Saudi Arabia, and finally provide an overview of the reported cases, their clinical features, and disease-causing variants. The study started with a search through neurology clinics and local databases and utilized genetic testing records after diagnosing a patient with NEDHND at our hospital (King Faisal Specialist Hospital and Research Centre, KFSHRC). Based on the search we have identified additional patients (in total, n = 10) with the disease and performed genetic testing using whole exome sequencing and confirmatory Sanger sequencing. We performed RT-PCR on RNA extracted from lymphoblastoid cell line from a patient who found to have an aberrant splicing variant. Finally, we comprehensively reviewed current literature and available data related to the disease. We present natural history of SPTBN4-associated neurodevelopmental disorder with hypotonia, neuropathy, and deafness in addition to four Saudi families with ten affected individuals who share clinical features of NEDHND. We report three known mutations and one novel nonsense variant, highlight atypical clinical features related to cerebellar involvement, confirm the pathogenicity of a splicing variant by RT-PCR, and review the findings of previously reported patients. Our study defines the clinical phenotype of a cohort of NEDHND in detail including the evolution of patients' clinical features, compares them to previously reported cases, and utilizes the existing data on the disease to direct development of a better prevention plan by means of genetic and preimplantation counseling. Our study may help and enable future clinical trials focusing on NEDHND in our country.

#4

Autosomal Recessive Cerebellar Ataxia-27 Caused by a Novel Loss-of-Function Variant of Ganglioside-Induced Differentiation Associated Protein 2 in a Spanish Family.

Neurology. Genetics2025 Jun

Our aim has been to describe a patient with a novel loss-of-function variant of the ganglioside-induced differentiation associated protein 2 (GDAP2) gene in homozygosis causing autosomal recessive cerebellar ataxia. We studied the virtual gene panel of hereditary ataxia with onset in adulthood (version 4.15) of PanelApp by means of whole exome sequencing. The validation of the variant of interest found was performed by Sanger sequencing. A segregation study was performed on family members. The patient is a man who started at age 32 years with dysarthria soon followed by cerebellar ataxia. On evolution, spasticity, cervical dystonia, and cognitive impairment were observed. A premature stop codon variant was detected in homozygosity in exon 2 of the GDAP2 gene: c.57_59delinsACCCCAGCT (p.Trp19*). It was also detected in the patient's mother and brother, who were heterozygous, and 4 nephews on the paternal side, who were also carriers of the variant. This null variant in the GDAP2 gene has not been previously described in the literature associated to ataxia, neither is it present in population databases. It is considered probably pathogenic (PVS1 and PM2) and as such can be classified from this study, providing further evidence on the association of GDAP2 with hereditary cerebellar ataxia.

#5

Delayed diagnosis of ataxia with oculomotor apraxia type 2 in a Peruvian patient, a case report.

Clinical neurology and neurosurgery2025 Apr

Ataxia with oculomotor apraxia type 2 (AOA2) is a rare autosomal recessive cerebellar ataxia characterized by progressive cerebellar ataxia, sensorimotor peripheral neuropathy, and occasional oculomotor apraxia. A 50-year-old male with a history of orthopedic shoe use since childhood presented with slowly progressive ataxia and neuropathy. Laboratory tests showed elevated serum alpha-fetoprotein levels and increased total cholesterol. Clinical whole genome sequencing identified a c.4853C > G (p.Ser1618Ter) homozygous pathogenic variant in SETX. The case highlights the challenges identifying rare disorders like AOA2 due to limited access to genetic testing and socioeconomic and healthcare barriers.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC64 artigos no totalmostrando 119

2026

Multisystemic Involvement in Autosomal Recessive Cerebellar Ataxia Type 8 Having a Novel SYNE1 Nonsense Variant.

Internal medicine (Tokyo, Japan)
2026

Juvenile-Onset Cerebrotendinous Xanthomatosis with Novel Compound Heterozygous CYP27A1 Mutations: Case Series and Literature Review.

Cerebellum (London, England)
2025

Systematic Phenotyping and Molecular Analysis of the Woozy Mouse: A Preclinical Model of Cerebellar Ataxia.

Molecular neurobiology
2025

Natural history of SPTBN4-related neurodevelopmental disorder with hypotonia, neuropathy, and deafness.

Orphanet journal of rare diseases
2025

Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models: a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA score.

BMC medical research methodology
2025

Autosomal Recessive Cerebellar Ataxia-27 Caused by a Novel Loss-of-Function Variant of Ganglioside-Induced Differentiation Associated Protein 2 in a Spanish Family.

Neurology. Genetics
2025

Spinocerebellar Ataxia 44 Caused by a Novel GRM1 Variant: Reviewing the Contrasting Pathogenic Mechanisms Underlying Two GRM1-Associated Hereditary Ataxias.

Cerebellum (London, England)
2025

Pendular Nystagmus: a Novel Feature of ANO10-Related Disorders.

Cerebellum (London, England)
2025

Delayed diagnosis of ataxia with oculomotor apraxia type 2 in a Peruvian patient, a case report.

Clinical neurology and neurosurgery
2025

Demystifying the Etiology of ILOCA in the Genomic Era: A Narrative Review.

Cerebellum (London, England)
2025

The First Case of Autosomal Recessive Cerebellar Ataxia with Prominent Paroxysmal Non-kinesigenic Dyskinesia Caused by a Truncating FGF14 Variant in a Turkish Patient.

Movement disorders : official journal of the Movement Disorder Society
2024

Longitudinal Analysis of Natural History Progression of Rare and Ultra-Rare Cerebellar Ataxias Using Item Response Theory.

Clinical pharmacology and therapeutics
2024

Revisiting Friedreich's Ataxia: Phenotypic and Imaging Characteristics.

Annals of Indian Academy of Neurology
2024

Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS).

The AAPS journal
2024

The genetic basis of early-onset hereditary ataxia in Iran: results of a national registry of a heterogeneous population.

Human genomics
2024

TPP1 Variants in Iranian patients: A Novel Pathogenic Homozygous Variant Causing Neuronal Ceroid Lipofuscinosis 2.

Molecular syndromology
2023

Genetic heterogeneity within a consanguineous family involving TTPA and SETX genes.

Journal of neurogenetics
2024

ARV1 Gene: A Novel Cause of Autosomal Recessive Cerebellar Ataxia with Elevated Alpha Fetoprotein.

Cerebellum (London, England)
2023

Compound heterozygous variants of THG1L result in autosomal recessive cerebellar ataxia.

Journal of human genetics
2023

Clinical Reasoning: A 48-Year-Old Man With Spasticity and Progressive Ataxia.

Neurology
2023

Ataxia-associated DNA repair genes protect the Drosophila mushroom body and locomotor function against glutamate signaling-associated damage.

Frontiers in neural circuits
2023

Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article.

Frontiers in neuroscience
2023

Novel Compound Heterozygous Mutations in the SYNE1 Gene in a Taiwanese Family: A Case Report and Literature Review.

Journal of movement disorders
2023

WWOX P47T partial loss-of-function mutation induces epilepsy, progressive neuroinflammation, and cerebellar degeneration in mice phenocopying human SCAR12.

Progress in neurobiology
2023

Expanding the Allelic Heterogeneity of ANO10-Associated Autosomal Recessive Cerebellar Ataxia.

Neurology. Genetics
2022

Heterozygous pathogenic variants in CWF19L1 in a Chinese family with spinocerebellar ataxia, autosomal recessive 17.

Journal of clinical laboratory analysis
2022

A Systematic Review of the Spectrum and Prevalence of Non-Motor Symptoms in Adults with Hereditary Cerebellar Ataxias.

Movement disorders clinical practice
2023

Hyperactive vestibular and visually enhanced vestibulo-ocular reflexes in autosomal recessive cerebellar ataxia type 3: a case report.

Journal of neurology
2022

A Rare Phenotype of Inherited Cerebellar Ataxia.

Cureus
2023

A novel biallelic variant further delineates PRDX3-related autosomal recessive cerebellar ataxia.

Neurogenetics
2022

Clinical and genetic study of ataxia with vitamin E deficiency: A case report.

World journal of clinical cases
2022

Treatable Ataxias: How to Find the Needle in the Haystack?

Journal of movement disorders
2022

Next-Generation Sequencing Identifies Novel PMPCA Variants in Patients with Late-Onset Dominant Optic Atrophy.

Genes
2024

Primary CoQ10 deficiency with a severe phenotype due to the c.901 C > T (p.R301W) mutation in the COQ8A gene.

The International journal of neuroscience
2022

Discovery of Therapeutics Targeting Oxidative Stress in Autosomal Recessive Cerebellar Ataxia: A Systematic Review.

Pharmaceuticals (Basel, Switzerland)
2022

Bringing light into the darkness: autosomal recessive cerebellar ataxia due to a recessive mutation in the SEPSECS gene.

Neurologia
2022

Autosomal recessive spinocerebellar ataxia SCAR8/ARCA1: first families detected in Spain.

Neurologia
2022

Clinical and Genetic Characterization of Brazilian Patients with Ataxia and Oculomotor Apraxia.

Movement disorders : official journal of the Movement Disorder Society
2022

Case Report: Late-Onset Autosomal Recessive Cerebellar Ataxia Associated With SYNE1 Mutation in a Chinese Family.

Frontiers in genetics
2022

A Novel SETX Mutation in a Taiwanese Patient with Autosomal Recessive Cerebellar Ataxia Detected by Targeted Next-Generation Sequencing, and a Literature Review.

Brain sciences
2022

Spinocerebellar ataxia recessive type 7 due to novel compound heterozygous variants in TPP1: First report from India.

Parkinsonism &amp; related disorders
2021

Spinocerebellar ataxia type 28 in a Chinese pedigree: A case report and literature review.

Medicine
2022

History of Ataxias and Paraplegias with an Annotation on the First Description of Striatonigral Degeneration.

Cerebellum (London, England)
2021

Genetic spectrum and clinical features in a cohort of Chinese patients with autosomal recessive cerebellar ataxias.

Translational neurodegeneration
2021

Three Adult-Onset Autosomal Recessive Ataxias: What Adult Neurologists Need to Know.

Neurology. Clinical practice
2021

Genetic Survey of Autosomal Recessive Peripheral Neuropathy Cases Unravels High Genetic Heterogeneity in a Turkish Cohort.

Neurology. Genetics
2021

Expanding the phenotype of AFG3L2 mutations: Late-onset autosomal recessive spinocerebellar ataxia.

Journal of the neurological sciences
2021

Retinal Architecture in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): Insights into Disease Pathogenesis and Biomarkers.

Movement disorders : official journal of the Movement Disorder Society
2021

Autosomal Recessive Cerebellar Ataxia 1: First Case Report Depicting a Variant in SYNE1 Gene in a Chilean Patient.

Cerebellum (London, England)
2021

Photoparoxysmal response in ADCK3 autosomal recessive ataxia: a case report and literature review.

Epileptic disorders : international epilepsy journal with videotape
2020

Synaptic Nuclear Envelope Protein 1 (SYNE 1) Ataxia with Amyotrophic Lateral Sclerosis-like Presentation: A Novel Synaptic Nuclear Envelope Protein 1 (SYNE 1) Gene Deletion Mutation from India.

Annals of Indian Academy of Neurology
2021

A Novel Variant in CWF19L1 Gene in a Family with Late-Onset Autosomal Recessive Cerebellar Ataxia 17.

Neurological research
2021

A first description of ataxia with vitamin E deficiency associated with MT-TG gene mutation.

Acta neurologica Belgica
2021

Autosomal Recessive Cerebellar Ataxia Type 1: Phenotypic and Genetic Correlation in a Cohort of Chinese Patients with SYNE1 Variants.

Cerebellum (London, England)
2021

Familial writer's cramp: a clinical clue for inherited coenzyme Q10 deficiency.

Neurogenetics
2020

Novel CHP1 mutation in autosomal-recessive cerebellar ataxia: autopsy features of two siblings.

Acta neuropathologica communications
2020

Generation and characterization of induced pluripotent stem cell (iPSC) line (JUCTCi002-A) from a patient with ataxia with oculomotor apraxia type 1 (AOA1) harboring a homozygous mutation in the APTX gene.

Stem cell research
2020

Identification of APTX disease-causing mutation in two unrelated Jordanian families with cerebellar ataxia and sensitivity to DNA damaging agents.

PloS one
2020

Primary coenzyme Q10 deficiency due to COQ8A gene mutations.

Molecular genetics &amp; genomic medicine
2020

Novel MAG Variant Causes Cerebellar Ataxia with Oculomotor Apraxia: Molecular Basis and Expanded Clinical Phenotype.

Journal of clinical medicine
2020

Late-onset autosomal recessive cerebellar ataxia and neuropathy with a novel splicing mutation in the ATM gene.

Journal of integrative neuroscience
2020

Concurrence of multiple sclerosis, oligodendroglioma, and autosomal recessive cerebellar ataxia with spasticity in the same patient: A challenging diagnosis.

Multiple sclerosis and related disorders
2019

Whole exome and targeted gene sequencing to detect pathogenic recessive variants in early onset cerebellar ataxia.

Clinical genetics
2021

Autosomal recessive cerebellar ataxia with spasticity due to a rare mutation in GBA2 gene in a large consanguineous Saudi family.

Genes &amp; diseases
2019

A novel truncating variant p.(Arg297*) in the GRM1 gene causing autosomal-recessive cerebellar ataxia with juvenile-onset.

European journal of medical genetics
2019

Identification of a novel mutation in the CACNA1C gene in a Chinese family with autosomal dominant cerebellar ataxia.

BMC neurology
2019

The Classification of Autosomal Recessive Cerebellar Ataxias: a Consensus Statement from the Society for Research on the Cerebellum and Ataxias Task Force.

Cerebellum (London, England)
2019

Exome sequencing found a novel homozygous deletion in ADCK3 gene involved in autosomal recessive spinocerebellar ataxia.

Gene
2019

Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).

Cerebellum (London, England)
2019

Species-specific differences in nonlysosomal glucosylceramidase GBA2 function underlie locomotor dysfunction arising from loss-of-function mutations.

The Journal of biological chemistry
2018

ADCK3-related Coenzyme Q10 Deficiency: A Potentially Treatable Genetic Disease.

Movement disorders clinical practice
2019

Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.

Movement disorders : official journal of the Movement Disorder Society
2019

A new MRI marker of ataxia with oculomotor apraxia.

European journal of radiology
2019

A study in a Polish ataxia cohort indicates genetic heterogeneity and points to MTCL1 as a novel candidate gene.

Clinical genetics
2019

ANO10 mutational screening in recessive ataxia: genetic findings and refinement of the clinical phenotype.

Journal of neurology
2018

SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.

Human genetics
2018

Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia.

International journal of molecular sciences
2018

SYNE1-related autosomal recessive cerebellar ataxia, congenital cerebellar hypoplasia, and cognitive impairment.

Clinics and practice
2018

Friedreich's Ataxia: Clinical Presentation of a Compound Heterozygote Child with a Rare Nonsense Mutation and Comparison with Previously Published Cases.

Case reports in neurological medicine
2018

GDAP2 mutations implicate susceptibility to cellular stress in a new form of cerebellar ataxia.

Brain : a journal of neurology
2020

PEX10-related autosomal recessive cerebellar ataxia with hearing loss.

Acta neurologica Belgica
2018

Rare case of Gordon Holmes syndrome.

BMJ case reports
2018

Mouse models of nesprin-related diseases.

Biochemical Society transactions
2018

SNX14 mutations affect endoplasmic reticulum-associated neutral lipid metabolism in autosomal recessive spinocerebellar ataxia 20.

Human molecular genetics
2018

Biallelic CHP1 mutation causes human autosomal recessive ataxia by impairing NHE1 function.

Neurology. Genetics
2018

Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.

JAMA neurology
2017

The Enigmatic Role of GBA2 in Controlling Locomotor Function.

Frontiers in molecular neuroscience
2018

Compound Heterozygous Inheritance of Mutations in Coenzyme Q8A Results in Autosomal Recessive Cerebellar Ataxia and Coenzyme Q10 Deficiency in a Female Sib-Pair.

JIMD reports
2017

A novel frameshift mutation of SYNE1 in a Japanese family with autosomal recessive cerebellar ataxia type 8.

Human genome variation
2017

A recessive ataxia diagnosis algorithm for the next generation sequencing era.

Annals of neurology
2017

SYNE1 related cerebellar ataxia presents with variable phenotypes in a consanguineous family from Turkey.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2017

βIII Spectrin Is Necessary for Formation of the Constricted Neck of Dendritic Spines and Regulation of Synaptic Activity in Neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2017

SLC25A46 Mutations Associated with Autosomal Recessive Cerebellar Ataxia in North African Families.

Neuro-degenerative diseases
2017

Early-Onset Friedreich's Ataxia With Oculomotor Apraxia.

Acta medica Iranica
2016

Posterior cerebellar Purkinje cells in an SCA5/SPARCA1 mouse model are especially vulnerable to the synergistic effect of loss of β-III spectrin and GLAST.

Human molecular genetics
2017

GBA2 Mutations Cause a Marinesco-Sjögren-Like Syndrome: Genetic and Biochemical Studies.

PloS one
2017

Autosomal Recessive Cerebellar Ataxia type 1 mimicking multiple sclerosis: A report of two siblings with a novel mutation in SYNE1 gene in a Saudi family.

Journal of the neurological sciences
2016

Seemingly dominant inheritance of a recessive ANO10 mutation in romani families with cerebellar ataxia.

Movement disorders : official journal of the Movement Disorder Society
2016

Genome sequencing reveals a splice donor site mutation in the SNX14 gene associated with a novel cerebellar cortical degeneration in the Hungarian Vizsla dog breed.

BMC genetics
2019

Keys to overcoming the challenge of diagnosing autosomal recessive spinocerebellar ataxia.

Neurologia
2016

Ataxia and Hypogonadotropic Hypogonadism with Intrafamilial Variability Caused by RNF216 Mutation.

Neurology international
2017

Anoctamin 10-Related Autosomal Recessive Cerebellar Ataxia: Comprehensive Clinical Phenotyping of an Irish Sibship.

Movement disorders clinical practice
2016

[Autosomal recessive spinocerebellar ataxias in Japan].

Rinsho shinkeigaku = Clinical neurology
2016

Executive and Attentional Disorders, Epilepsy and Porencephalic Cyst in Autosomal Recessive Cerebellar Ataxia Type 3 Due to ANO10 Mutation.

European neurology
2016

UBA5 Mutations Cause a New Form of Autosomal Recessive Cerebellar Ataxia.

PloS one
2016

AarF Domain Containing Kinase 3 (ADCK3) Mutant Cells Display Signs of Oxidative Stress, Defects in Mitochondrial Homeostasis and Lysosomal Accumulation.

PloS one
2016

Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism.

Brain : a journal of neurology
2016

Autosomal recessive cerebellar ataxia caused by a homozygous mutation in PMPCA.

Brain : a journal of neurology
2015

Investigation of mitochondrial DNA variations among Indian Friedreich's ataxia (FRDA) patients.

Mitochondrion
2015

A new model to study neurodegeneration in ataxia oculomotor apraxia type 2.

Human molecular genetics
2016

Pathogenic CWF19L1 variants as a novel cause of autosomal recessive cerebellar ataxia and atrophy.

European journal of human genetics : EJHG
2016

A homozygous mutation of VWA3B causes cerebellar ataxia with intellectual disability.

Journal of neurology, neurosurgery, and psychiatry
2015

Blood metal levels and related antioxidant enzyme activities in patients with ataxia telangiectasia.

Neurobiology of disease
2015

A variant of Nesprin1 giant devoid of KASH domain underlies the molecular etiology of autosomal recessive cerebellar ataxia type I.

Neurobiology of disease
2015

PMPCA mutations cause abnormal mitochondrial protein processing in patients with non-progressive cerebellar ataxia.

Brain : a journal of neurology
2015

Autosomal recessive cerebellar ataxia 3 due to homozygote c.132dupA mutation within the ANO10 gene--reply.

JAMA neurology
2015

Autosomal recessive cerebellar ataxia 3 due to homozygote c.132dupA mutation within the ANO10 gene.

JAMA neurology
2015

Mitochondrial recessive ataxia syndrome: A neurological rarity not to be missed.

Journal of the neurological sciences
2015

SNP Analysis and Whole Exome Sequencing: Their Application in the Analysis of a Consanguineous Pedigree Segregating Ataxia.

Microarrays (Basel, Switzerland)

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Ataxia cerebelosa autossômica recessiva.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Ataxia cerebelosa autossômica recessiva

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Multisystemic Involvement in Autosomal Recessive Cerebellar Ataxia Type 8 Having a Novel SYNE1 Nonsense Variant.
    Internal medicine (Tokyo, Japan)· 2026· PMID 41850837mais citado
  2. Juvenile-Onset Cerebrotendinous Xanthomatosis with Novel Compound Heterozygous CYP27A1 Mutations: Case Series and Literature Review.
    Cerebellum (London, England)· 2026· PMID 41528650mais citado
  3. Natural history of SPTBN4-related neurodevelopmental disorder with hypotonia, neuropathy, and deafness.
    Orphanet journal of rare diseases· 2025· PMID 40781329mais citado
  4. Autosomal Recessive Cerebellar Ataxia-27 Caused by a Novel Loss-of-Function Variant of Ganglioside-Induced Differentiation Associated Protein 2 in a Spanish Family.
    Neurology. Genetics· 2025· PMID 40469082mais citado
  5. Delayed diagnosis of ataxia with oculomotor apraxia type 2 in a Peruvian patient, a case report.
    Clinical neurology and neurosurgery· 2025· PMID 40068357mais citado
  6. Novel homozygous SYNE1 missense variant in late onset autosomal recessive cerebellar ataxia 1: a case report.
    Ther Adv Neurol Disord· 2026· PMID 41913895recente
  7. Systematic Phenotyping and Molecular Analysis of the Woozy Mouse: A Preclinical Model of Cerebellar Ataxia.
    Mol Neurobiol· 2025· PMID 41350949recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1172(Orphanet)
  2. MONDO:0015244(MONDO)
  3. GARD:18718(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q4826996(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Ataxia cerebelosa autossômica recessiva
Compêndio · Raras BR

Ataxia cerebelosa autossômica recessiva

ORPHA:1172 · MONDO:0015244
Prevalência
1-9 / 100 000
Herança
Autosomal recessive
Ensaios
2 ativos
Medicamentos
11 registrados
Início
All ages
Prevalência
3.3 (Portugal)
MedGen
UMLS
C5575375
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades